Wave Life Sciences (WVE) Cash from Operations Growth (1y) (2015 - 2026)
Wave Life Sciences (WVE) Cash from Operations Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.97 Bn | 466.18 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.05 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.42 Bn | 959.66 Mn | 158.60% |
| 10 | Wave Life Sciences | 1.19 Bn | 642.40 Mn | - | 5.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.53% |
| Dec 31, 2025 | 22.62% |
| Sep 30, 2025 | 3.90% |
| Jun 30, 2025 | -67.51% |
| Mar 31, 2025 | -88.56% |
| Dec 31, 2024 | -31.32% |
| Sep 30, 2024 | -34.89% |
| Jun 30, 2024 | 26.27% |
| Mar 31, 2024 | -139.09% |
| Dec 31, 2023 | 0.60% |
| Sep 30, 2023 | -34.36% |
| Jun 30, 2023 | -29.27% |
| Mar 31, 2023 | 314.49% |
| Dec 31, 2022 | -375.47% |
| Sep 30, 2022 | 9.01% |
| Jun 30, 2022 | -206.58% |
| Mar 31, 2022 | 10.15% |
| Dec 31, 2021 | 77.61% |
| Sep 30, 2021 | -39.72% |
| Jun 30, 2021 | 75.35% |